Palma C
I explore all this in a feature story published today, which marks the kick off of a new series from The Globe and Mail called Skinny Inc, about the big business of weight-loss drugs: Also published today is a companion piece from my colleague Kelly Grant who digs deeper into the research and patient experience of these drugs: We have more coming in the series over the coming weeks, including stories on influencers, insurance coverage, the effect on the food industry and more
The American Diabetes Association (ADA) recently released revised guidelines and safety measures for exercise and physical activity for those with type 1 diabetes, type 2 diabetes (2)
Support Performance
For many people, Ozempic is not a safe weight loss aid
Mayo KE, Miller LJ, Bataille D, Dalle S, Goke B, Thorens B, et al